Glycogen synthase kinase 3 (gsk-3) and suicide: a systematic review
DOI:
https://doi.org/10.34119/bjhrv8n6-394Keywords:
GSK-3 (glycogen synthase kinase 3), suicidal behavior, depression, neuroinflammation, lithiumAbstract
Introduction: Glycogen synthase kinase 3 (GSK-3) has been associated with a lot of diseases, such as Alzheimer’s Disease and diabetes. Its role in depression is connected to stress and neuroinflammation. Lithium is an essential inhibitor of GSK-3. Some studies have suggested that the use of this psychiatric medication may lower suicide rates. Here, we outline the current understanding and discoveries regarding the link between GSK-3 and suicide. Method: We used the PRISMA statement and defined the PECOS strategy, such as Population (P) = individuals; exposure (E) = GSK-3 alteration function; comparison (C) = without GSK-3 alteration function; outcome (O) = suicide; and study design(S) = all kinds of studies with an association between GSK-3 and suicide. Results: Twelve studies were included in this review. GSK-3 appears to be related to suicidal behavior by activating inflammatory pathways, activating genes, altering neurotransmission, and increasing impulsivity. Clinical studies do not present robust results that allow defining an epidemiological profile of greater risk for suicidal behavior in association with changes in the functioning of GSK-3. Conclusion: The interference of GSK-3 functioning in suicidal behavior seems inevitable, with solid evidence from laboratory animal studies. However, there is a need for further clinical studies on this crucial topic to answer better some questions about the association between GSK-3 and suicide.
References
Allen, J. P. (2011). The Debate between a Man and His Soul: A Masterpiece of Ancient Egyptian Literature. Koninklijke Brill NV.
Alvarez, G., Muñoz-Montaño, R., Satrústegui, J., Avila, J., Bogónez, E., & Díaz-Nido, J. (1999). Lithium protects cultured neurons against B-amyloid-induced neurodegeneration. FEBS Letters, 453, 260-264.
Beaulieu , J. M., Gainetdinov, R. R., & Caron, M. G. (2007). The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci, 28(4), 166-172.
Beaulieu, J. M. (2012). A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health. J Psychiatry Neurosci, 37(1), 7-16.
Bernard, V., Vaiva, G., Masson, M., & Geoffroy, P. A. (2016). Lithium and suicide prevention in bipolar disorder. L'Encéphale, 42(3), 234-241.
Beurel, E., & Jope, R. S. (2014). Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits. Transl Psychiatry, 4, e488.
Beurel, E., Toups, M., & Nemeroff, C. B. (2020). The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron, 107(2), 234-256.
Can, A., Schulze, T. G., & Gould, T. D. (2014). Molecular actions and clinical pharmacogenetics of lithium therapy. Pharmacol Biochem Behav, 123, 3-16. https://doi.org/10.1016/j.pbb.2014.02.004
Chaignet, A. E. (1874). Pythagore et la Philosophie Pythagoricenne (12 ed., Vol. 1). Librairie Académique.
Clinical Evidence of the Efficacy of Ketamine in the
De Berardis, D., Fornaro, M., Valchera, A., Cavuto, M., Perna, G., Di Nicola, M.,…Tomasetti, C. (2018). Eradicating Suicide at Its Roots: Preclinical Bases and
Doble, B. W., Kelly, K. F., & Woodgett, J. R. (2011). Molecular Mechanisms Underlying Pluripotency and Lineage Commitment – The Role of GSK-3. In Embryonic Stem Cells - Basic Biology to Bioengineering. InTech. https://doi.org/10.5772/23842
Embi, N., Rylatt, D. B., & Cohen, P. (1980). Glycongen Synthase Kinase-3 from Rabbit Skeletal Muscle. Eur J Biochem, 107, 519-527.
Giotakos, O. (2018). Is impulsivity in part a lithium deficiency state? Psychiatriki, 29(3), 264-270.
Harkin, E. F., Nasrallah, G., Le François, B., & Albert, P. R. (2023). Transcriptional Regulation of the Huma 5-HT1A Receptor Gene by Lithium: Role of Deaf1 and GSK3beta. Int J Mol Sci, 24, 15620.
Hernandez, F., Lucas, J. J., & Avila, J. (2013). GSK3 and Tau: Two Convergence Points in Alzheimer's Disease. Journal of Alzheimer's Disease, 33, S141-144.
Jiménez, E., Arias, B., Mitjans, M., Goikolea, J. M., Roda, E., Sáiz, P. A.,…Benabarre, A. (2013). Genetic variability at IMPA2, INPP1 and GSK3B increases the risk of suicidal behavior in bipolar patients. European Neuropsychopharmacology, 23(11), 1452-1462.
Jones, G. H., Rong, C., Shariq, A. S., Mishra, A., & Machado-Vieira, R. (2020). Intracellular Signaling Cascades in Bipolar Disorder. In A. H. Young & M. F. Juruena (Eds.), Bipolar Disorder: From Neuroscience to Treatment. Current Topics in Behavioral Neurosciences (Vol. 48, pp. 101-132). Springer.
Jope, R. S., & Johnson, G. V. W. (2004). The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci, 29(2), 95-102.
Kalkman, H. O. (2011). Circumstantial evidence for a role of glutamine-synthetase in suicide. Medical Hypotheses, 905-907.
Karege, F., Perroud, N., Burkhardt, S., Fernandez, R., Ballmann, E., La Harpe, R., & Malafosse, A. (2012). Protein levels of B-catenin and activation of glycogen synthase kinase-3B in major depression. A study with postmortem prefontal cortex. Journal of Affective Disorders, 136, 185-188.
Karege, F., Perroud, N., Burkhardt, S., Schwald, M., & Ballmann, E. (2007). Alteration in Kinase Activity But Not in Protein Levels of Protein Kinase B and Glycogen Synthase Kinase-3beta in Ventral Prefrontal Cortex of Depressed Suicide Victims. Biol Psychiatry, 61, 240-245.
Kessler, R. C., & J, B. E. (2013). The epidemiology of depression across cultures. Annu Rev Public Health, 34, 119-138.
Lai, S., Wang, P., Gong, J., & Zhang, S. (2023). New insights into the role of GSK-3β in the brain: from neurodegenerative disease to tumorigenesis. PeerJ, 11, e16635.
Landa, J. I., Duarte, J. M., & Appiani, F. J. (2021). Conductas suicidas en adolescentes: factores de riesgo, fisiopatología y el uso de litio como terapia preventiva. Prev Méd Argent, 107(8), 397-405.
Malhi, G. S., Das, P., Outhred, T., Irwin, L., Morris, G., Hamilton, A.,…Mannie, Z. (2018). Understanding suicide: Focusing on its mechanisms through a lithium lens. Journal of Affective Disorders, 241, 338-347.
McCallum, R. T., & Perreault, M. L. (2021). Glycogen Synthase Kinase-3. Cells, 10.
Munner, A. (2017). Wnt and GSK3 Signalling Pathways in Bipolar Disorder: Clinical and Thereapeutic Implication. Clinical Psychopharmacology and Neuroscience, 15(2), 100-114.
Musazzi, L., Seguini, M., Mallei, A., Treccani, G., Pelizzari, M., Tornese, P.,…Tardito, D. (2014). Time-dependent activation of MAPK/Erk1/2 and Akt/GSK3 cascades: modulation by agomelatine. BMC Neuroscience, 15(119).
Page, M. J., McKenzie, J. E., Bossuyt, P. M., & et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev, 10.
Pandey, G. N., Dwivedi, Y., Rizavi, H. S., Teppen, T., Gaszner, G. L., Roberts, R. C., & Conley, R. R. (2009). GSK-3b Gene Expression in Human Postmortem Brain: Regional Distribution, Effects of Age and Suicide. Neurochem Res, 34, 274-285.
Ren, X., Rizavi, H. S., Khan, M. A., Dwivedi, Y., & Pandey, G. N. (2013). Alterede Wnt signalling in the teenage suicide brain: focus on glycogen synthase kinase-3B and B-catenin. International Journal of Neuropsychopharmacology, 16, 945-945.
Rodrigues, J. F. R. (2022). O que é o suicídio: perfil epidemiológico de suicídio na cidade de Marília: proposições para prevenção (Vol. 1). Dialética.
Rodrigues, J. F. R., Rodrigues, L. P., & Araújo Filho, G. M. (2023). Alzheimer's Disease and Suicide: An Integrative Literature Review. Current Alzheimer Research, 20(11), 758-768. https://doi.org/10.2174/0115672050292472240216052614
Rodrigues, J. F. R., Rodrigues, L. P., Rodrigues, F. C. P., Rubatino, F. V. M., Atalaia da Silva, K. C., Serna Rodriguez, M. F.,…de Araújo Filho, G. M. (2024). Tau and Depression: A Systematic Review. Preprints. https://www.preprints.org/manuscript/202408.0925/v1
Sai Varshini, M., Aishwarya Reddy, R., & Thaggikuppe Krishnamurthy, P. (2024). Unlocking hope: GSK-3 inhibitors and Wnt pathway activation in Alzheimer's therapy. J Drug Target, 32(8), 909-917.
Sarai, S. K., Mekala, H. M., & Lippmann, S. (2018). Lithium Suicide Prevention: A Brief Review and Reminder. Innov Clin Neurosci, 15, 30-32.
Shneidman, E. (1985). Definition of suicide. Interscience.
Treatment of Suicidal Behaviors. Int. J. Mol. Sci, 19.
Woodgett, J. R. (1990). Molecular cloning and expression of glycogen synthasekinase-3/Factor A. he EMBO Journal, 9(8), 2431-2438.
Yoon, H. K., Kim, Y. K., Lee, B. H., & Hwang, J. A. (2009). Association study of -1727 A/T and -50C/T GSK-3 beta gene polymorphism with suicidal behavior in depressed patients. European Neuropsychopharmacology, 19, S225-226.
Yoon, H.-K., & Kim, Y.-K. (2010). Association between glycogen synthase kinase-3b gene polymorphisms and major depression and suicidal behavior in a Korean population. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34, 331-334.
